comparemela.com

Page 13 - Biocon Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biocon Leads India Push Into Weight Loss Drugs as Patents Begin to Lapse

Biocon Leads India Push Into Weight Loss Drugs as Patents Begin to Lapse
bloomberg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloomberg.com Daily Mail and Mail on Sunday newspapers.

United kingdomNovo nordiskBiocon ltd

Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot

Weight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in generic supply. The Bengaluru-based company secured UK approval for the first generic version of liraglutide injectible, positioning itself as a leader in this evolving market.

United kingdomSiddharth mittalNovo nordiskEli lillyNovo nordisk ozempicKiran mazumdar shawPeter bainsReddy laboratories ltdSun pharmaceutical industries ltdEris lifesciences ltdBiocon ltdNovo nordisk to eli lilly coCipla ltdNational health servicesExecutive officer siddharth mittalLaboratories ltd

Biocon leads India push into weight loss drugs as patents lapse

The Bengaluru-based firm has scored an early win among its peers with the UK approval for the first generic version of liraglutide injectible, which is losing patent protection in November.

United kingdomEli lillyKiran mazumdar shawSiddharth mittalNovo nordisk ozempicNovo nordiskPeter bainsReddy laboratories ltdEris lifesciences ltdNational health servicesCipla ltdBiocon ltdSun pharmaceutical industries ltdNovo nordisk to eli lilly coExecutive officer siddharth mittalLaboratories ltd

vimarsana © 2020. All Rights Reserved.